Clinical trial

Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01424709

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE2

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2014-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

Gemcitabine, Docetaxel, CPT-11,CisplatinDRUG

gemcitabine/cisplatinDRUG

Sponsors & collaborators

Tongji Universitylead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01424709 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.